Cargando…
Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Autores principales: | Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600099/ https://www.ncbi.nlm.nih.gov/pubmed/34792786 http://dx.doi.org/10.1007/s12325-021-01967-5 |
Ejemplares similares
-
Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021) -
Era of COVID-19 in Multiple Sclerosis Care
por: Krett, Jonathan D., et al.
Publicado: (2023) -
Correction to: Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID‑19 era
por: Toscano, Simona, et al.
Publicado: (2022) -
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
por: Cross, Anne H., et al.
Publicado: (2022) -
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey
por: Tumani, Hayrettin, et al.
Publicado: (2023)